Functional Magnetic Resonance Imaging to Monitor Disease Progression: A Prospective Study in Patients with Primary Membranoproliferative Glomerulonephritis.

Autor: Villa G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Daina E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Brambilla P; Unit of Radiology, ASST Papa Giovanni XXIII, Bergamo, Italy., Gamba S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Leone VF; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Carrara C; Unit of Nephrology and Dialysis, ASST Papa Giovanni XXIII, Bergamo, Italy., Rizzo P; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Noris M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Remuzzi A; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo, Italy., Caroli A; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Jazyk: angličtina
Zdroj: Nephron [Nephron] 2024; Vol. 148 (6), pp. 367-378. Date of Electronic Publication: 2023 Nov 03.
DOI: 10.1159/000534893
Abstrakt: Introduction: Primary membranoproliferative glomerulonephritis (MPGN) is a rare kidney disease with poor prognosis and no specific therapies. The disease heterogeneity and the difficulty of performing repeated kidney biopsies pose big challenges. This study investigates the correlation between non-contrast enhanced magnetic resonance imaging (MRI) and histologic and clinical findings in patients with primary MPGN.
Methods: Patients with primary MPGN underwent baseline and 1-year kidney MRI in addition to biopsy and laboratory testing as part of a prospective MRI subproject of a clinical trial (ClinicalTrials.gov identifier NCT03723512). Diffusion-weighted and phase-contrast MRI were used to investigate kidney diffusivity and perfusion. Peritubular interstitial volume and fibrosis were quantified on kidney biopsies.
Results: Seven patients with primary MPGN (18[17-21] years, 43% females) were included. Kidney biopsies showed variable degree of global and segmental glomerular sclerosis ([5-30]% and [10-60]%), mild interstitial fibrosis (<10%), and increased peritubular interstitial volume ([19-40]%). MRI and laboratory parameters changed very differently from patient to patient over 1 year. Peritubular interstitial volume and glomerular sclerosis negatively associated with renal blood flow (RBF) (rho = -0.81 and -0.77), and positively with renal vascular resistance (RVR) (rho = 0.65 and 0.73). Urinary albumin to creatinine ratio (uACR) negatively associated with RBF and filtration fraction (FF) (rho = -0.86 and -0.6), while positively with RVR (rho = 0.88). uACR decrease was associated with kidney diffusivity increase (rho = -0.5). Measured glomerular filtration rate (GFR) positively associated with kidney diffusivity, RBF, and FF (rho = 0.87, 0.85, and 0.59), while negatively with RVR (rho = -0.89); GFR increase was associated with kidney diffusivity, RBF, and FF increase (rho = 0.77, 0.7, and 0.7) and RVR decrease (rho = -0.7).
Conclusion: The strong correlation found between MRI and histologic and clinical findings, despite the rather limited number of patients, highlights MRI potential to monitor disease progression in patients with rare kidney disease.
(© 2023 The Author(s). Published by S. Karger AG, Basel.)
Databáze: MEDLINE
Externí odkaz: